The effectiveness of evaluating mumps vaccine effectiveness

Clinical Infectious Diseases

Volumn 45, Issue 4, 2007, Pages 467-469

  Brunell, Philip A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MUMPS VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; CLINICAL EFFECTIVENESS; DISEASE TRANSMISSION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EVALUATION; GOLD STANDARD; HIGH RISK POPULATION; HUMAN; MORBIDITY; MUMPS; MUMPS VIRUS; NONHUMAN; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES; VACCINE FAILURE; VIRUS HEMAGGLUTINATION; VIRUS ISOLATION; VIRUS SHEDDING;

DISEASE OUTBREAKS; HUMANS; MUMPS; MUMPS VACCINE; MUMPS VIRUS; TREATMENT OUTCOME; UNITED STATES;

EID: 34547622644     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520027     Document Type: Note

References (12)

1. Centers for Disease Control and Prevention. Mumps activity - United States, January 1-October 7, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:1152-3.
2. Brunell PA, Brickman A, O'Hare D, et al. Ineffectiveness of isolation of patients as a method of preventing the spread of mumps. N Engl J Med 1968; 279:1357-61.
3. Fine PE, Clarkson JA. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet 1982; 1:666-9.
4. Centers for Disease Control and Prevention. Update: multistate outbreak of mumps - United States, January 1-May 2, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:559-63.
5. Peltola H, Kulkarni PS, Dapre SV, et al. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45:459-66 (in this issue).
6. Shehab ZM, Brunell PA, Cobb E. Epidemiologic standardization of a test for susceptibility to mumps. J Infect Dis 1984; 149:810-2.
7. Brunell PA, Brickman A, Steinberg S. Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). Am J Dis Child 1969; 118:435-40.
8. Weibel RE, Stokes J, Buynak EB, et al. Live, attenuataed mumps-virus vaccine 3: clinical and serologic aspects in a field evaluation. New Engl J Med 1967; 276:245-51.
9. Hilleman MR, Weibel RE, Buynak EB, et al. Live, attenuataed mumps-virus vaccine 4: protective efficacy as measured in a field evaluation. New Engl J Med 1967; 276:252-8.
10. Reed D, Brown G, Merrick R, et al. A mumps epidemic on St. George Island, Alaska. JAMA 1967; 199:113-7.
11. Brunell PA, Brickman A, Steinberg S, et al. Parotitis in children who had previously received mumps vaccine. Pediatrics 1972; 50:441-4.
12. Lievens A, Brunell PA. Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles. J Clin Microbiol 1986; 24:391-4.